BTMD vs MRMD: stock comparison and AI forecast
Biote Corp. (BTMD) and Marimed Inc. (MRMD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BTMD Biote Corp.
- Market Cap
- $30M
- P/E Ratio
- 2.5x
- Size
- small-cap
- AI Forecast
MRMD Marimed Inc.
- Market Cap
- $26M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BTMD is 1.1 times larger than MRMD by market capitalization ($30M against $26M).
- BTMD yields 13.59% in dividends; MRMD pays none.
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BTMD | MRMD |
|---|---|---|
| Market Cap | $30M | $26M |
| P/E Ratio | 2.54x | – |
| P/B Ratio | – | 0.58x |
| Dividend Yield | 13.59% | – |
| EPS | $0.41 | $-0.05 |
| Book Value/Share | – | $0.11 |
| Revenue/Share | $6.40 | $0.41 |
| FCF/Share | $0.69 | $0.02 |
Profitability & Margins
| Metric | BTMD | MRMD |
|---|---|---|
| ROE | – | -33.5% |
| ROA | – | -7.7% |
| ROIC | – | -1.9% |
| Gross Margin | 68.6% | 35.6% |
| Operating Margin | 4.5% | -1.6% |
| Net Margin | – | -9.2% |
| EBT Margin | 3.1% | -6.3% |
| Tax Rate | 31.0% | -45.8% |
Financial Health
| Metric | BTMD | MRMD |
|---|---|---|
| Current Ratio | 1.43x | 0.92x |
| Quick Ratio | 0.82x | 0.34x |
| D/E Ratio | – | 3.26x |
| Financial Leverage | – | 4.37x |
| Interest Coverage | – | 0.2x |
| Working Capital | $13M | -$5M |
Cash Flow
| Metric | BTMD | MRMD |
|---|---|---|
| Operating Cash Flow | $24M | $9M |
| Free Cash Flow | $20M | $8M |
| Capital Spending | -$4M | -$1M |
| OCF Growth YoY | -41.2% | 368.3% |
| FCF Growth YoY | -42.9% | – |
| FCF/Sales | 10.8% | 4.9% |
| CapEx/Sales | 2.5% | 0.8% |
Operational Efficiency
| Metric | BTMD | MRMD |
|---|---|---|
| Asset Turnover | – | 0.83x |
| Receivables Turnover | 23.5x | 17.5x |
| Inventory Turnover | 3.1x | 2.9x |
| Fixed Assets Turnover | 14.3x | 1.9x |
| Days Sales Outstanding | 16 days | 21 days |
| Days Inventory | 116 days | 127 days |
| Payables Period | 42 days | 46 days |
| Cash Conversion Cycle | 90 days | 102 days |
Income Statement
| Metric | BTMD | MRMD |
|---|---|---|
| Total Revenue | $184M | $164M |
| Operating Income | $15M | -$3M |
| Net Income | – | -$15M |
| SG&A Expense | $111M | – |
| Cost of Goods Sold | $58M | $105M |
Dividend & Shareholder Information
| Metric | BTMD | MRMD |
|---|---|---|
| Dividends Per Share | $0.14 | – |
| Payout Ratio | 34.1% | – |
| Shares Outstanding | 29M | 403M |
| EPS Growth | 7.9% | – |
BTMD vs MRMD: stock comparison and AI forecast
Which is bigger, BTMD or MRMD?
BTMD is 1.1 times larger than MRMD by market capitalization ($30M against $26M).
Which one does Intratio's AI model rank higher, BTMD or MRMD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.